Core Competitors

CLB Stock  USD 17.75  0.79  4.26%   
Core Laboratories competes with Bristow, RPC, NOV, Oceaneering International, and Cactus; as well as few others. The company runs under Energy Equipment & Services sector within Energy industry. Analyzing Core Laboratories competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Core Laboratories to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Core Laboratories Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Core Laboratories competition on your existing holdings.
  
At present, Core Laboratories' Return On Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.32, whereas Return On Tangible Assets are forecasted to decline to 0.07. At present, Core Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
15.0017.7320.46
Details
Intrinsic
Valuation
LowRealHigh
14.1316.8619.59
Details
Naive
Forecast
LowNextHigh
14.3417.0719.81
Details
6 Analysts
Consensus
LowTargetHigh
17.5919.3321.46
Details

Core Laboratories Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Core Laboratories and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Core and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Core Laboratories does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
OIIVTOL
WHDVTOL
WHDOII
WHDNOV
GEOSNOV
OISRES
  
High negative correlations   
CCLPDNOW
CCLPOIS
CCLPWHD
NRGEOS
CCLPRES
NRNOV

Risk-Adjusted Indicators

There is a big difference between Core Stock performing well and Core Laboratories Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Core Laboratories' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
VTOL  1.40 (0.01)(0.04) 0.05  1.72 
 2.92 
 14.67 
RES  1.90  0.03 (0.01) 0.15  2.38 
 4.40 
 18.40 
NOV  1.26 (0.11) 0.00 (0.16) 0.00 
 2.34 
 12.99 
OII  1.89  0.01 (0.01) 0.10  2.10 
 4.10 
 18.18 
WHD  1.55  0.02 (0.01) 0.13  1.84 
 3.55 
 16.96 
DNOW  1.51  0.35  0.19  0.57  1.23 
 3.71 
 16.46 
OIS  2.15  0.33  0.11  0.70  2.15 
 5.15 
 16.39 
GEOS  2.33 (0.23) 0.00 (0.67) 0.00 
 3.54 
 27.12 
NR  1.76  0.01 (0.03) 0.21  2.10 
 3.73 
 14.86 
CCLP  2.66 (0.09) 0.00 (0.08) 0.00 
 8.11 
 17.49 

Cross Equities Net Income Analysis

Compare Core Laboratories and related stocks such as Bristow Group, RPC Inc, and NOV Inc Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioFree Cash Flow Yield
Operating Cash Flow Per ShareStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
Capex To RevenuePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingIncome Quality
RoePe Ratio
Return On Tangible AssetsEarnings Yield
Intangibles To Total AssetsCurrent Ratio
Receivables TurnoverDebt To Equity
Capex Per ShareRevenue Per Share
Debt To AssetsDays Sales Outstanding
Book Value Per ShareInvested Capital
Average PayablesEv To Sales
Average InventoryCash Per Share
Net Current Asset ValueTangible Asset Value
Ev To Operating Cash FlowEv To Free Cash Flow
Net Debt To E B I T D ATangible Book Value Per Share
Graham NumberShareholders Equity Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion CycleDays Of Sales Outstanding
Enterprise Value Multiple
2010201120122013201420152016201720182019202020212022202320242025
VTOL(336.8 M)(336.8 M)7.8 M18.7 M17.1 M8.7 M(16 M)(28.2 M)13.9 M(14 M)(56.3 M)(15.7 M)18 M(6.8 M)(6.1 M)(6.4 M)
RES(40.9 M)296.4 M274.4 M166.9 M245.2 M(99.6 M)(141.2 M)162.5 M175.4 M(87.1 M)(212.2 M)7.2 M218.4 M195.1 M224.4 M235.6 M
NOV200 KB2.5 B2.3 B2.5 B(769 M)(2.4 B)(237 M)(31 M)(6.1 B)(2.5 B)(245 M)155 M993 M893.7 M938.4 M
OII(11.2 M)235.7 M289 M371.5 M428.3 M231 M24.6 M166.4 M(212.3 M)(348.4 M)(496.8 M)(49.3 M)25.9 M97.4 M112 M57 M
WHD21.2 M21.2 M21.2 M21.2 M21.2 M21.2 M(8.2 M)66.5 M65.3 M156.3 M59.2 M67.5 M110.2 M169.2 M194.5 M204.3 M
OIS902 K322.5 M448.6 M421.3 M179 M28.6 M(46.4 M)(84.8 M)(19.1 M)(231.8 M)(468.4 M)(64 M)(9.5 M)12.9 M11.6 M11 M
GEOS6.6 M35.1 M69.6 M36.9 M(32.6 M)(46 M)(56.8 M)(19.2 M)(146 K)(19.2 M)(14.1 M)(22.9 M)12.2 M(6.6 M)(5.9 M)(5.6 M)
MRC69.6 M29 M118 M152.1 M144.1 M(331.6 M)(83 M)50 M74 M39 M(274 M)(39 M)75 M114 M131.1 M137.7 M
NOA8.2 M(21.2 M)(1.5 M)69.2 M(1.2 M)(7.5 M)(445 K)5.3 M15.3 M36.9 M49.2 M51.4 M67.4 M63.1 M72.6 M76.2 M
NGS382 K9.8 M12.7 M14.4 M14.1 M10.1 M6.5 M19.9 M426 K(13.9 M)1.8 M(9.2 M)(569 K)4.7 M4.3 M4.7 M
CHX51.7 M51.7 M51.7 M51.7 M51.7 M51.7 M(12.8 M)110.6 M94 M52.2 M(742.4 M)113.3 M155 M314.2 M361.4 M379.4 M
EFXT120.5 M(7 M)71.8 M55.9 M70.3 M45.7 M(104.7 M)97.6 M101 M151.6 M69.1 M(18.5 M)(100.9 M)(110.9 M)(99.8 M)(94.8 M)

Core Laboratories and related stocks such as Bristow Group, RPC Inc, and NOV Inc Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Core Laboratories financial statement analysis. It represents the amount of money remaining after all of Core Laboratories NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Core Laboratories Competitive Analysis

The better you understand Core Laboratories competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Core Laboratories' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Core Laboratories' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CLB VTOL RES NOV OII WHD DNOW OIS GEOS NR
 4.26 
 17.75 
Core
 0.32 
 34.20 
Bristow
 3.89 
 6.17 
RPC
 0.49 
 14.47 
NOV
 0.40 
 25.37 
Oceaneering
 2.06 
 60.39 
Cactus
 2.20 
 15.34 
Now
 0.38 
 5.25 
Oil
 0.11 
 9.33 
Geospace
 0.82 
 7.24 
NR Old
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Core Laboratories Competition Performance Charts

Five steps to successful analysis of Core Laboratories Competition

Core Laboratories' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Core Laboratories in relation to its competition. Core Laboratories' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Core Laboratories in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Core Laboratories' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Core Laboratories, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Core Laboratories position

In addition to having Core Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Farming Thematic Idea Now

Farming
Farming Theme
Companies producing farming products and providing services for farmers. The Farming theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Core Laboratories Correlation with its peers.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.316
Earnings Share
0.54
Revenue Per Share
11.158
Quarterly Revenue Growth
0.072
Return On Assets
0.0589
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.